White House relaunches free COVID test program as part of 'winter preparedness plan'
The White House announced Thursday that it plans to relaunch a program that provided free COVID tests to American households in need through the U.S. Postal Service. The free test program is a part of the Biden administration's COVID-19 "winter preparedness plan" to face rising COVID cases, The New York Times reports.
Administration officials paused the USPS COVID test program in early September due to concerns that the demand for free test kits threatened to deplete supplies before winter. They warned that the White House could not afford to buy more tests, so they paused the program to preserve the "limited remaining supply" for a potential surge of COVID-19 during the winter holiday season, per Politico. Over 600 million home tests were sent out to households nationwide before federal officials put the program on hold. To restart the program without additional congressional funding, officials relied on what the White House called "limited existing funding." Households can request four tests on the covidtests.gov website, with deliveries beginning next week.
Unpausing the free test program is a part of the White House's agenda to head off a potential surge in COVID cases that could put pressure on medical centers that are already strained. Cases of the flu and respiratory syncytial virus, or RSV, are already overwhelming medical professionals, and COVID cases are rising. Reported cases have seen a roughly 55 percent increase over the past two weeks, and COVID-related deaths have risen 65 percent in the same period, per the Times. Hospitalizations have also increased by over 20 percent. The rise in cases has been largely driven by two Omicron subvariants, BQ.1 and BQ.1.1, which now make up around two-thirds of the cases reported in the U.S.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
6 homes for entertainingFeature Featuring a heated greenhouse in Pennsylvania and a glamorous oasis in California
-
Obesity drugs: Will Trump’s plan lower costs?Feature Even $149 a month, the advertised price for a starting dose of a still-in-development GLP-1 pill on TrumpRx, will be too big a burden for the many Americans ‘struggling to afford groceries’
-
The ‘Kavanaugh stop’Feature Activists say a Supreme Court ruling has given federal agents a green light to racially profile Latinos
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
